Health and Healthcare
BioNTech Raises Over $400 Million to Boost COVID-19 Efforts
Published:
Last Updated:
BioNTech S.E. (NASDAQ: BNTX) has been one of the leading companies in the race to a COVID-19 vaccine. Its partnership with Pfizer Inc. (NYSE: PFE) has brought BioNTech to the top, with its shares rising over 160% year to date. Now, it’s time to capitalize.
The company announced a secondary offering of 5,000,000 American depositary shares (ADSs), each representing one ordinary share, with an overallotment option to purchase an additional 750,000 ADSs.
The underwriters for the offering are JPMorgan, BofA Securities, Berenberg, UBS, Canaccord Genuity, Commerzbank, Wolfe Capital Markets and Bryan Garnier.
Certain new and existing investors, including Pfizer, have indicated an interest in purchasing up to an aggregate of $200 million in ADSs. However, these indications of interest are not binding agreements or commitments to purchase.
The pricing for the offering has yet to be determined. With shares already posting a massive gain this year, BioNTech will make a nice chunk of change to put toward its research and operations.
At the most recent closing price of $88.20, the entire offering would be valued up to $441 million. Note that the company has a market cap of $21 billion, so this offering would constitute roughly 2% of the total cap.
BioNTech stock traded up about 6% to $93.83 on Tuesday, in a 52-week range of $12.52 to $105.00. The consensus price target is $55.39.
24/7 Wall St.Credit Card Companies Are Doing Something Nuts
Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.
It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.
We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.